Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Bupropion on Smoking Lapse Behavior
NCT00580853Phase 2Completed
- Sponsor
- Yale University
- Start
- Apr 2007
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline, bupropion in nicotine dependence, sponsored by Yale University. Started Apr 2007; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00580853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580853.